[Federal Register Volume 66, Number 229 (Wednesday, November 28, 2001)]
[Notices]
[Page 59443]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-29537]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary and Alternative Medicine; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Alternative Medicine Special Emphasis Panel.
    Date: December 7, 2001.
    Time: 1 pm to 3 pm.
    Agenda: To review and evaluate contract proposals.
    Place: NCCAM/Office of Scientific Review, 6707 Democracy Blvd, 
Ste. 106, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Martin H. Goldrosen, Ph.D., Chief, Office of 
Scientific Review, National Center for Complementary, and 
Alternative Medicine, National Institutes of Health, 6707 Democracy 
Blvd, Ste. 106, Bethesda, MD 20892-5475, (301) 451-6331, 
[email protected].

    Dated: November 16, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-29537 Filed 11-27-01; 8:45 am]
BILLING CODE 4140-01-M